関連する実験動画

Updated: Apr 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K

エボラ出血熱の流行における実験薬の思いやりある使用 - 著者の回答

Annette Rid1, Ezekiel J Emanuel2

  • 1Department of Social Science, Health & Medicine, King's College London, London WC2R 2LS, UK.

Lancet (London, England)
|December 3, 2014
PubMed
まとめ

No abstract available in PubMed .

さらに関連する動画

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment
08:22

Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment

Published on: July 19, 2017

10.9K

関連する実験動画

Last Updated: Apr 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment
08:22

Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment

Published on: July 19, 2017

10.9K

関連する概念動画

Cross-reactivity00:42

Cross-reactivity

34.1K
Overview
34.1K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

418
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
418
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
Jove
Visualize
お問い合わせ